CONMED
CNMD
246 hedge funds and large institutions have $1.12B invested in CONMED in 2026 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 84 increasing their positions, 83 reducing their positions, and 30 closing their positions.
43% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 30
4% more funds holding
Funds holding: 236 → 246 (+10)
1% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 83
0.04% less ownership
Funds ownership: 110.62% → 110.58% (-0.04%)
7% less capital invested
Capital invested by funds: $1.21B → $1.12B (-$89.3M)
79% less call options, than puts
Call options by funds: $291K | Put options by funds: $1.39M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$19.4M |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
+$14M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$7.22M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$5.82M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
+$5.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
-$14.9M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$11M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
-$7.46M |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$5.61M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.78M |
CNMD Hedge Fund Activity: Q2 2026 in Review
246 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q2 2026, worth a combined $1.12B — down 7.4% from $1.21B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new CNMD positions and 30 closed out — a net gain of 13 holders — while 84 added to existing stakes and 83 trimmed.
The largest buyer was Paradigm Capital Management Inc, opening a new position worth an estimated $19.4M. The largest seller was Cooke & Bieler, cutting an estimated $14.9M.
- 246 institutional investors held CONMED (CNMD) as of Q2 2026, up from 236 in Q1 2026.
- Funds reported $1.12B of CONMED stock for Q2 2026, down 7.4% quarter-over-quarter.
- 43 funds opened new CONMED positions in Q2 2026 and 30 closed out, a net change of +13 holders.
- The largest CONMED buyer in Q2 2026 was Paradigm Capital Management Inc, an estimated $19.4M added.
- The largest CONMED seller in Q2 2026 was Cooke & Bieler, an estimated $14.9M sold.
Based on aggregated 13F filings for Q2 2026.